Abdel-Wahab & Abd-Allah
|
2000
|
streptozotocin-induced hyperglycaemia
|
serum
|
5 mg/kg
|
mice
|
[62]
|
Lagneux et al.
|
2000
|
ischemia-reperfusion injury
|
heart
|
1-10 mg/kg
|
rats
|
[63]
|
Kaptanoglu et al.
|
2000
|
experimental spinal cord injury
|
spinal tissues
|
100 mg/kg
|
rats
|
[64]
|
Kaneko et al.
|
2000
|
ischemic reperfusion injury
|
heart
|
100µM
|
rats
|
[65]
|
Qi et al.
|
2000
|
chromium(III)-induced DNA damage
|
|
0.51 µM
|
isolated DNA
|
[66]
|
Khaldy et al.
|
2000
|
dopamine autoxidation-induced hydroxy radical formation
|
|
1-1000 µM
|
in vitro
|
[67]
|
Calvo et al.
|
2001
|
α-naphthylisothiocyanate-induced injury
|
liver
|
10 mg/kg
|
rats
|
[68]
|
Otsuka et al.
|
2001
|
water-immersion restraint stress-induced gastric mucosal lesions
|
stomach
|
100 ng/rat icv
|
rats
|
[69]
|
Hara et al.
|
2001
|
cisplatin-induced nephrotoxicity
|
kidney
|
5 mg/kg
|
rats
|
[70]
|
Salvi et al.
|
2001
|
free radicals-induced protein structural damage
|
cell-free system
|
up to 1 mM
|
|
[71]
|
Cabeza et al.
|
2001
|
ischemia-reperfusion injury
|
gastrointestinal tissues
|
5-20 mg/kg
|
rats
|
[72]
|
Othman et al.
|
2001
|
indomethacin-induced oxidative stress
|
gastric and testicular tissues
|
10 mg/kg
|
rats
|
[73]
|
Montilla et al.
|
2001
|
extra-hepatic bile duct ligation oxidative stress
|
liver
|
0.5 mg/kg
|
rats
|
[74]
|
Jajte et al.
|
2001
|
iron ions and 7 mT 50 Hz magnetic field-indiced damage
|
lymphocytes
|
0.5-1.0 mM
|
rats
|
[75]
|
Ryoo et al.
|
2001
|
ultraviolet-B induced
|
dermal fibroblasts
|
1 nM
|
human
|
[76]
|
Xu et al.
|
2001
|
doxorubicin-induced toxicity
|
heart
|
90 mg/kg
|
rats
|
[77]
|
Szárszoi et al.
|
2001
|
ischemia-reperfusion-induced injury
|
heart
|
10-10 000 nmol/L
|
rats
|
[78]
|
Xu & Ashraf
|
2002
|
doxorubicin-induced myocyte injury
|
heart
|
1 mM
|
rats
|
[79]
|
Arslan et al.
|
2002
|
bleomycin-induced fibrosis
|
lung
|
10 mg/kg
|
rats
|
[80]
|
Hsu et al.
|
2002
|
phosphine-induced lipid and DNA oxidation
|
brain
|
1 mM
|
rats
|
[81]
|
Bonilla et al.
|
2002
|
extension of life span and stress resistance
|
whole body
|
100 µg/L
|
flies
|
[82]
|
Parmar et al.
|
2002
|
copper-mediated free radical damage
|
|
5 mM
|
liver homogenates
|
[83]
|
Gupta et al.
|
2002
|
acute ischemic stroke
|
brain
|
80 mg/kg
|
rats
|
[84]
|
Bilici et al.
|
2002
|
ethanol-induced gastric mucosal damage
|
stomach
|
10 mg/kg
|
rats
|
[85]
|
Görgün et al.
|
2002
|
Streptozotocin-induced plasma thiobarbituric acid-reactive substances blockade
|
plasma
|
150 µg/kg (x56)
|
rats
|
[86]
|
Tomás-Zapico et al.
|
2002
|
delta-aminolevulinic acid-induced oxidative damage
|
Harderian gland
|
500 µg/kg
|
hamsters
|
[87]
|
Leaden et al.
|
2002
|
lipid peroxidation of long chain polyunsaturated fatty acids
|
liver
|
10 mg/kg
|
rats
|
[88]
|
Srivastava et al.
|
2002
|
posttraumatic seizures
|
brain
|
50 mg/kg
|
rats
|
[89]
|
Abdel-Wahab et al.
|
2002
|
dibromoacetonitrile-induced oxidative stress
|
stomach
|
10 mg/kg
|
mice
|
[90]
|
Martin et al.
|
2002
|
oxidative stress
|
astrocytes
|
10nM - 1mM
|
rats
|
[91]
|
Rao et al.
|
2002
|
STZ-induced hyperglycemia
|
plasma
|
6 mg/kg
|
rats
|
[92]
|
Perotti et al.
|
2002
|
delta-aminolevulinic acid phototherapy-induced damages
|
|
8 mM
|
LM2 cell line
|
[93]
|
Kocic et al.
|
2002
|
diabetes-induced oxidative stress
|
mesangial cells
|
1 to 100 µM
|
rats
|
[94]
|
Jaworek et al.
|
2003
|
ischemia/reperfusion-induced acute pancreatitis
|
gut
|
10-50 mg/kg
|
rats
|
[95]
|
Mayo et al.
|
2003
|
metal-catalyzed reaction-induced oxidative protein damage
|
cell-free system
|
50 µM to 100 mM
|
in vitro
|
[96]
|
Jahovic et al.
|
2003
|
methotrexate-induced oxidative injury
|
liver & kidneys
|
10 mg/kg
|
rats
|
[97]
|
Sener et al.
|
2003
|
ischemia/reperfusion-induced oxidative injury
|
liver
|
10 mg/kg
|
rats
|
[98]
|
Chen et al.
|
2003
|
myocardial infarction
|
heart
|
150 µg/kg
|
mice
|
[99]
|
Mayo et al.
|
2003
|
peroxyl radical-induced oxidative damage
|
catalase
|
250 µM
|
in vitro
|
[100]
|
Bonnefont-Rousselot et al.
|
2003
|
peroxyl radical-induced oxidative damage
|
LDL
|
250 µM
|
in vitro
|
[101]
|
Requintina & Oxenkrug
|
2003
|
lipopolysaccharide-induced toxicity
|
several organs
|
5 mg/kg
|
mice
|
[102]
|
|
|
|
|
|
|
|
Cabeza et al.
|
2003
|
ischemia-reperfusion-induced lesions
|
stomach
|
20 mg/kg
|
rats
|
[103]
|
Erol et al.
|
2004
|
gamma radiation-induced damages
|
brain
|
100 mg/kg (x5)
|
rats
|
[104]
|
Guajardo et al.
|
2003
|
ascorbate-Fe2+ dependent lipid peroxidation
|
retina (in vitro)
|
10 mM
|
bovine
|
[105]
|
Yan et al.
|
2002
|
transcatheter arterial chemoembolization-induced liver damage
|
liver
|
20 mg
|
humans
|
[106]
|
Sperling et al.
|
2003
|
iodoacetate-induced neurotoxicity
|
neuronal cells
|
1 mM
|
rats
|
[107]
|
Ciuffi et al.
|
2003
|
ultraviolet exposure
|
corneal cells
|
10 µM
|
rabbits
|
[108]
|
Sahin et al.
|
2003
|
heat stress-related depression
|
whole birds
|
40 mg/kg diet
|
quails
|
[109]
|
Basile et al.
|
2004
|
pathogenesis of sepsis
|
liver
|
1 - 10 µM
|
rat hepatocytes
|
[110]
|
Gitto et al.
|
2004
|
post-surgical distress
|
neonates
|
10 mg/kg (x10)
|
humans
|
[111]
|
Kilic et al.
|
2004
|
mild focal ischemia-induced neuronal death
|
mice
|
4 mg/kg (x2)
|
mice
|
[112]
|
Gupta et al.
|
2004
|
enhances phenytoin and carbamazepine antiseizure effect
|
drug metabolism
|
100 to 300 mg/kg
|
mice
|
[113]
|
Leja-Szpak et al.
|
2004
|
acute pancreatitis
|
pancreas
|
up to 250 mg/kg of precursor
|
mice
|
[114]
|
Liang et al.
|
2004
|
oxidative stress-induced macular degeneration
|
retinal pigment epithelial cells
|
0.1-200 µM
|
humans
|
[115]
|
Sahin et al.
|
2004
|
heat-induced performance inhibition
|
whole animals
|
40 mg/kg diet
|
quails
|
[116]
|
Görgün et al.
|
2004
|
streptozotocin-induced glutathione depletion
|
plasma
|
150 μg/kg (x42)
|
rats
|
[117]
|
Othman et al.
|
2004
|
heavy metals-induced severe haematopoietic disorders
|
blood and bone marrow
|
30 mg/kg
|
rats
|
[118]
|
Sener et al.
|
2004
|
ifosfamide-induced Fanconi syndrome
|
kidney and bladder tissues
|
10 mg/kg
|
rats
|
[119]
|
Jou et al.
|
2004
|
oxidative stress-induced apoptosis
|
astrocytes
|
100 µM
|
rats
|
[120]
|
Yildirim et al.
|
2004
|
cyclophosphamide-induced hemorrhagic cystitis
|
bladder
|
5 mg/kg (x2)
|
rats
|
[121]
|
Siu et al.
|
2004
|
nitric oxide-induced eye toxicity
|
retina
|
5 mg/kg
|
rats
|
[122]
|
Feng et al.
|
2004
|
beta-amyloid-induced neurotoxicity
|
brain
|
10 mg/kg
|
mice
|
[123]
|
Feng et al.
|
2004
|
progressive memory deficits
|
brain
|
5 - 20 mg/kg
|
rats
|
[124]
|
Ogeturk et al.
|
2005
|
CCl4-induced toxicity
|
kidney
|
25 mg/kg
|
rats
|
[125]
|
Padillo et al.
|
2004
|
experimental cholestasis-induced cell death
|
liver
|
500 µg/kg
|
rats
|
[126]
|
Kilic et al.
|
2004
|
focal cerebral ischemia
|
brain
|
4 mg/kg
|
mice
|
[127]
|